| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NTLA | Common Stock | Sale | $9,247 | -307 | -0.68% | $30.12 | 45,146 | 03 Jan 2024 | Direct | F1 |
| transaction | NTLA | Common Stock | Sale | $126,707 | -4,301 | -9.5% | $29.46 | 40,845 | 03 Jan 2024 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Sale of 307 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on December 31, 2023. |
| F2 | Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2024, and does not represent a volitional trade by the Reporting Person. |